Chemical activators of Rslcan-1 include a variety of compounds that instigate a cascade of biochemical events leading to the protein's activation. Phorbol 12-myristate 13-acetate (PMA) and 4β-Phorbol act as direct activators of protein kinase C (PKC). PKC, once activated, phosphorylates Rslcan-1, which is a necessary post-translational modification for its activation. Forskolin, through its ability to elevate intracellular cAMP levels, indirectly activates protein kinase A (PKA). The activated PKA has a multitude of targets, one of which can be Rslcan-1, leading to its phosphorylation and subsequent activation. Similarly, Ionomycin functions by increasing intracellular calcium levels, which activates calcium-dependent kinases. These kinases can phosphorylate Rslcan-1, thereby contributing to its activation.
Moreover, Thapsigargin disrupts calcium homeostasis, indirectly leading to the activation of kinases that phosphorylate Rslcan-1. Okadaic Acid, Calyculin A, and Cantharidin inhibit protein phosphatases, which normally act to dephosphorylate proteins. By inhibiting these phosphatases, these chemicals ensure that Rslcan-1 remains phosphorylated, thus retaining its active state. Anisomycin activates stress-activated protein kinases, another group of kinases capable of phosphorylating Rslcan-1, ensuring its activation. Bisindolylmaleimide I, although a PKC inhibitor, can lead to the compensatory activation of alternative pathways that can converge on the activation of Rslcan-1. Mevalonolactone is critical for the synthesis of isoprenoids, which are necessary for the post-translational modification of Rslcan-1, a step important for its functional activation. Lastly, Endothall, like Okadaic Acid, Calyculin A, and Cantharidin, maintains Rslcan-1 in a phosphorylated and active form by inhibiting protein phosphatases. All these chemicals, through their respective mechanisms, ensure the functional activation of Rslcan-1 by promoting its phosphorylation state, a key determinant of its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate Rslcan-1, leading to its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Raises intracellular calcium levels, activating calcium-dependent kinases that can phosphorylate and activate Rslcan-1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Disrupts calcium homeostasis, leading to activation of pathways that phosphorylate and activate Rslcan-1. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases, preventing dephosphorylation of Rslcan-1, thus maintaining it in an active state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases that can phosphorylate and activate Rslcan-1. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits PKC, leading to compensatory activation of alternative pathways that activate Rslcan-1. | ||||||
Phorbol | 17673-25-5 | sc-253267 | 5 mg | $270.00 | 1 | |
Similar to PMA, activates PKC which subsequently can phosphorylate and activate Rslcan-1. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits protein phosphatases leading to a sustained phosphorylated and active form of Rslcan-1. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Inhibits serine/threonine phosphatases, ensuring Rslcan-1 remains phosphorylated and active. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Inhibits protein phosphatases, similar to Cantharidin and Calyculin A, maintaining Rslcan-1 in an activated state. | ||||||